Renée Bultijnck
@ReneeBultijnck
Followers
496
Following
3K
Media
177
Statuses
815
Postdoctoral Researcher Ghent University, exercise oncology, HRQoL, PROM, cancer survivorship, prostate cancer.
Ghent, Belgium
Joined December 2015
🔥New paper🔥 #prostatecancer #ADT #HRQoL
@BramDL @ugent_fge @cghysel @PieterUvin @azsintjan @PSAVlaanderen #ThinkBlueVlaanderen 🔥Take-home M 🔥 1. Patient organization-initated survey is feasible #HRQoL #RWD 2. Insights sexual & hormonal #PRO 3. Use multimodal #communication
1
13
14
🚨 Publication alert! A new international study validates the @EORTC #QualityofLife PATSAT-C33 and OUT-PATSAT7 questionnaires as robust tools for measuring patient satisfaction in cancer care. 🌟 📰 Access the paper: https://t.co/qbjsedHlU9
#GivingVoice2Patients #CancerResearch
0
2
4
🚀🔥⚡️At #ESTRO2025,Dr. @piet_ost presented results from the DART Phase II trial (SBRT ± Darolutamide) in oligorecurrent prostate cancer. QoL mostly stable over 24 weeks, though more fatigue & hormonal symptoms in SBRT+DARO arm. Further toxicity data coming. #ProstateCancer #SBRT
0
4
18
🎯 DART trial: SBRT vs SBRT + 6mo Darolutamide for oligorecurrent #prostatecancer. QoL results at #ESTRO25 ✅ Grade 3 events are low in both arms ✅ QoL remains stable after SBRT ❌ Gynecomastia biggest issue with darolutamide
0
12
44
Full house @uzgent @ugent_fge department #radiotherapy @MietVdm #implementing #innovations in #healthcare @mariajacobsnl Maastro
0
1
4
A #prostatecancer masterclass by @BramDL on the first @ProBioTrial results. My take home message: Physicians choosing the treatment based on their “experience” is not the best option. First randomized results in mCRPC of ARPI vs Tax! Paper here https://t.co/HvoiSF2sIx
1
15
28
Groundbreaking scientific results on ARPi vs Taxanes in metastatic castration-resistant #ProstateCancer and quality of life studies take center stage. 🔬 Thanks to @BramDL and @ReneeBultijnck for their expert insights! #mCRPC #Oncology
1
2
4
Prof. Henrik Grönberg opening the 2nd #ProBioTrial International Investigators Meeting in Stockholm! 🌍 Healthcare professionals from 🇸🇪 🇧🇪 🇳🇴 🇨🇭 are coming together to push the boundaries of #ProstateCancer cancer research and treatment. Let’s make an impact! 💪
1
4
10
No reasons not to participate in this highly innovative, patient-centered trial! @ProBioTrial @BramDL @piet_ost @ReneeBultijnck
0
4
9
@ReneeBultijnck showing the first QoL 📊 of the @ProBioTrial. Patient receiving an ARTA in mCRPC show a clear gain in QoL, while Tax treated patients see a sharp decline in QoL. Food for thought.
0
1
3
⏳Counting down to the 🥈@ProBioTrial International Investigators Meeting 📢 This Monday the @ProBioTrial investigators, coordinators, nurses, technicians, and patient organisations from 🇸🇪🇧🇪🇳🇴🇨🇭 are coming together for two days of new data, discussions, and fun 🙏 Stay tuned!
1
6
7
0
2
12
First day @EORTC_QLG #EORTC #QLG Autumn meeting - looking forward to hearing all the project updates, connect & reconnect with friends/colleagues & be inspired for future ideas/projects
0
1
7
Compliance to MDT recs in OMD pts: 👉83.7% of MDT recommendations correctly implemented 👉Reasons for major deviations: physician decision, patient comorbidity or patient decision. 👉Major deviations associated with more than one distant met and worse OS https://t.co/z2D6i8hYWl
3
19
54
📚New scoping review from @EORTC #QualityofLife Group examined the current state of electronic patient-reported outcomes (PROs), how they are collected in cancer randomised controlled trials, & the reporting quality of these. 👉 https://t.co/xR32zgZfmU
#CancerResearch @BMJ_Open
0
4
10
More data (OptiTrain) showing exercise improves outcomes in #breastcancer Still multiple questions on dose and delivery. Maybe there isn’t an ‘ideal’ but - more trials coming Exercise good ✅ Behavioural change - hard! Exercise prescriptions may be helpful? #ESMO24
1
7
15
Proud to be part of #international @ProBioTrial team @BramDL @piet_ost & present our first #HRQoL results in #mCRPC, ARPI vs taxane vs SOC @myESMO #ESMO24 travel funded by @FWOVlaanderen
0
4
14
@BuffartLaurien presents compelling evidence that exercise-based prehab has +ve effects on efficacy of RT and SACT. Explores the links between exercise and improved gut biome diversity. Some evidence to support but work in progress. @UKONSmember #EONS17 #ESMO24 @cancernurseEU
0
3
3
0
34
76
Outstanding discussion by @ChrisSweens1 Highlighting the importance of optimal first-line therapy, more available therapies, and biomarkers to improve patient outcomes. No one-size-fits-all approach—adapting as new data emerges is crucial. #ESMO24 @oncoalert @myESMO #cancer
0
13
20
0
6
9